Effects of Gum Arabic Supplementation in Hemodialysis Patients
- Conditions
- Kidney Failure, Chronic
- Interventions
- Dietary Supplement: Gum ArabicOther: Placebo
- Registration Number
- NCT03789708
- Lead Sponsor
- University of Khartoum
- Brief Summary
Gum Arabic is a naturally produced gummy exudate from Acacia Senegal tree. It's a complex polysaccharide with proven prebiotic properties. Through its effect on intestinal bacteria, it's expected to reduce systemic levels of toxic bacterial metabolites and reduce inflammatory markers.By increasing fecal bacteria mass it's also expected to reduce blood urea level. These changes are potentially beneficial to hemodialysis patients who suffer from disturbed intestinal flora and a chronic inflammatory status. The investigators hypothesize that supplementing the diet of hemodialysis patients with Gum Arabic for four weeks would reduce inflammatory markers, increase total anti-oxidant capacity and reduce blood urea concentration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Adult end-stage renal disease patients maintained on regular hemodialysis
- Chronic liver disease
- Malignant condition
- Inflammatory bowel disease
- History of bowel resection
- Long term antibiotic therapy
- Pregnancy or lactation
- Current use of immunosuppressive medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A Gum Arabic Patients will receive 10 g of Gum Arabic supplementation daily for four weeks. Gum Arabic is provided in the form of easily soluble granules. Participants are asked to dissolve it in water or juice and drink it. C Gum Arabic Patients will receive 20 g of Gum Arabic supplementation daily for four weeks D Gum Arabic Patients will receive 40 g of Gum Arabic supplementation daily for four weeks B Placebo Patients will receive 5 g of maltodextrin supplementation daily for four weeks. Maltodextrin is an easily digested polysacharide provided in the form of soluble whitish powder that has no taste or odor. Participants are asked to dissolve it in water or juice and drink it.
- Primary Outcome Measures
Name Time Method Highly sensitive C-reactive protein (hs CRP) level 4 weeks Change in serum level of highly sensitive C-reactive protein.
Total anti-oxidant capacity 4 weeks Change in serum total anti-oxidant capacity
Blood urea level 4 weeks Change in urea blood level
- Secondary Outcome Measures
Name Time Method Serum uric acid 4 weeks Change in serum uric acid level
Serum calcium 4 weeks Change in serum calcium level
Serum phosphorus 4 weeks Change in serum phosphorus level
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Doctor Salma Center for Kidney Diseases
🇸🇩Khartoum, Sudan